UK markets open in 1 hour 37 minutes

NIKKEI 225
38,268.18
-5.87(-0.02%)
HANG SENG
18,168.46
+405.43(+2.28%)
CRUDE OIL
79.49
+0.49(+0.62%)
GOLD FUTURES
2,324.50
+13.50(+0.58%)
DOW
37,903.29
+87.37(+0.23%)
Bitcoin GBP
45,815.09
-2,120.34(-4.42%)

Family finances

Who is the breadwinner in your family and does it matter?

Glaukos Corporation (GKOS)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

98.91

+2.91

(+3.03%)

At close: 04:00PM EDT

97.00

-1.91

(-1.93%)

After hours:

06:58PM EDT

Loading interactive chart…

Zacks
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates
Glaukos (GKOS) delivered earnings and revenue surprises of -20.69% and 8.83%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.com
Glaukos Corp (GKOS) Q1 2024 Earnings: Misses Analyst EPS Forecast, Surpasses Revenue Expectations
Comprehensive Analysis of Glaukos Corp's Latest Financial Performance
Business Wire
Glaukos Announces First Quarter 2024 Financial Results
ALISO VIEJO, Calif., May 01, 2024--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2024. Key highlights include: